Episodes
Wednesday Dec 01, 2021
Wednesday Dec 01, 2021
This talk reviews the need for natural compounds to be considered in the management of COVID-19 with such compounds being generic, cheap and easily available. The talk reviews the evidence base for xanthohumol a prenylated flavanoid derived from humulus lupulus (hops) to be considered for further examination in the management of COVID-19. This talk reviews the anti-viral and anti-inflammatory effects of xanthohumol and also assesses other natural compounds such as curcumin in addition to the importance of vitamins and minerals such as vitamin D, vitamin C, zinc and selenium.
Speaker Bio:
Prof Martyn Caplin is a consultant gastroenterologist at the Royal Free Hospital in London and in private practice at Wellington Hospital, London. In addition to his practice in gastroenterology he is lead physician for the Neuroendocrine Tumour European Centre of Excellence at the Royal Free Hospital, leading a multidisciplinary clinical team as well as heading a research programme into these rare cancers across UCL. His research interests include gastrointestinal peptides, understanding the molecular pathogenesis of GI cancers as well as treatment. He was a founder of the European Neuroendocrine Tumour Society in 2004 as well as being past Chairman of ENETS (2014-2016) and was also a founder and Past-Chairman of the UK & Ireland Neuroendocrine Tumour receiving a Lifetime Achievement Award in recognition of his clinical leadership and research. In the field of gastroenterology he was the clinical lead for “NHS Evidence” for Gastroenterology and Liver diseases (under the auspices of NICE), chairing annual evidence updates into gastrointestinal and liver disorders. He has published over 200 peer review papers, written multiple book chapters and co-authored two books. He regularly lectures both nationally and internationally.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.